Finance

Lists
XBRANE:STO
Xbrane Biopharma AB
11,40 SEK
+1,79%
(+0,20) 1D
16 қаз., 17:29:49 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for XBRANE...
Open
11,10 SEK
High
11,55 SEK
Low
11,00 SEK
Mkt. cap
234,90 млн
Avg. vol.
50,09 мың
Volume
28,25 мың
52-wk high
32,65 SEK
52-wk low
5,42 SEK
EPS
-3,64 SEK
Shares outstanding
20,61 млн
No. of employees
29
Open
11,10 SEK
High
11,55 SEK
Low
11,00 SEK
Mkt. cap
234,90 млн
Avg. vol.
50,09 мың
Volume
28,25 мың
52-wk high
32,65 SEK
52-wk low
5,42 SEK
EPS
-3,64 SEK
Shares outstanding
20,61 млн
No. of employees
29
News stories
From web sources and news partners
About Xbrane Biopharma AB
CEOMartin Åmark
Employees29
Founded2008
Headquarters-
Sector-
Websitexbrane.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
10,12 млн
9,09 млн
17,34 млн
46,75 млн
Cost of goods sold
15,10 млн
7,41 млн
10,51 млн
38,67 млн
Cost of revenue
15,10 млн
7,41 млн
10,51 млн
38,67 млн
Research and development expenses
9,84 млн
58,87 млн
9,95 млн
10,10 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,95 млн
6,58 млн
7,57 млн
6,99 млн
Operating expense
19,67 млн
23,26 млн
15,86 млн
10,88 млн
Total operating expenses
34,78 млн
30,66 млн
26,37 млн
49,55 млн
Operating income
-24,66 млн
-21,58 млн
-9,03 млн
-2,80 млн
Other non operating income
-1,00 мың
-4,36 млн
-
1,00 мың
EBT including unusual items
-23,73 млн
-26,20 млн
-12,70 млн
-11,28 млн
EBT excluding unusual items
-23,73 млн
-26,20 млн
-12,70 млн
-5,58 млн
Income tax expense
6,00 мың
-
89,00 мың
-
Effective tax rate
-0,03%
-
-0,70%
-
Other operating expenses
1,88 млн
-42,19 млн
-1,66 млн
-6,21 млн
Net income
-24,03 млн
-26,48 млн
-13,07 млн
-11,42 млн
Net profit margin
-237,47%
-291,41%
-75,40%
-24,42%
Earnings per share
-1,17
-1,27
-
-
Interest and investment income
-
2,82 млн
-
-
Interest expense
-196,00 м.
-
-2,19 млн
-2,28 млн
Net interest expenses
-196,00 м.
2,82 млн
-2,19 млн
-2,28 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,87 млн
-16,01 млн
-6,28 млн
-67,00 мың
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары